Please try another search
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Robert C. Glen | - | - | Member of the Scientific Advisory Board |
Robert L. Holland | 67 | - | Member of the Scientific Advisory Board |
Karsten Ahlbeck | - | - | Member of the Scientific Advisory Board |
Anders Jacobson | 56 | 2022 | Independent Director |
Scott Boyer | 62 | 2015 | CEO & Director |
Fredrik Hubinette | 55 | 2020 | Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review